Division of Endocrinology/Diabetes Amanda House — Buffalo, New York

Division of Endocrinology/Diabetes Amanda House is a clinical research site located in Buffalo, New York, United States 14203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Division of Endocrinology/Diabetes Amanda House has participated in 1 clinical trials.

Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Sponsors: Rhythm Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Buffalo

Browse all research sites in New York · View every site in Buffalo

• University of Buffalo Kaleida Health
• The Lung & Cystic Fibrosis Center, University of Buffalo Pediatric Associates, Inc., Women & Children's Hospital of Buffalo
• University at Buffalo/Buffalo General Medical Center
• Oishei Children's Hospital University at Buffalo
• Millarad Fillmore Hospital, SUNY
• State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences
• University at Buffalo School of Medicine
• University at Buffalo, Department of Neurosurgery
• Women and Chidren's Hospital Of Buffalo
• University at Buffalo Clinical and Translational Research Center
• VA Western New York Healthcare System, Buffalo, New York
• State University Of New York

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Division of Endocrinology/Diabetes Amanda House?

Division of Endocrinology/Diabetes Amanda House has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Division of Endocrinology/Diabetes Amanda House conducted?

Division of Endocrinology/Diabetes Amanda House has 1 clinical trials on record. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Is Division of Endocrinology/Diabetes Amanda House accredited by Crixeo Clinical Trials?

Division of Endocrinology/Diabetes Amanda House has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Division of Endocrinology/Diabetes Amanda House?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.